|
For Immediate Release |
Contact: Shawn M. Harrington |
|
November 25, 2003 |
(860) 644-1551 |
GERBER SCIENTIFIC ANNOUNCES FISCAL 2004 SECOND QUARTER RESULTS
Board Votes to Recommend Declassification
SOUTH WINDSOR, CT -- Gerber Scientific, Inc. (NYSE: GRB)
today reported fiscal second quarter earnings of $0.12 per diluted share on revenues of $130.3 million for the period endedFor the six months ended October 31, 2003, the Company reported earnings of $0.14 per diluted share on revenues of $259.2 million, compared with year-ago earnings of $0.30 per diluted share on revenues of $254.7 million. Excluding a prior year sale of a discontinued operation, earnings from continuing operations for the six months ended October 31, 2002 were $0.24 per diluted share.
Foreign currency translation had the effect of increasing revenue by $8.2 million and $18.3 million for the three- and six-month periods ended October 31, 2003, respectively, versus the prior year comparable periods.
Second quarter highlights included:
Commenting on the second quarter results, Marc T. Giles, president and chief executive officer said "We did not see an upturn in our business in the second quarter and visibility is low. While I am pleased with the progress made with our turnaround initiatives, especially shared services cost reductions, competitive pricing and unfavorable sales mix outweighed the cost benefits realized to date. We remain focused on cost reduction while uncertainty in global economic conditions continues. Going forward, our strategy remains unchanged: reduce debt, improve Spandex's operations, implement shared services, and reinvigorate innovation."
Fiscal Second Quarter Consolidated Results
Fiscal second quarter revenue and order entry were $130.3 million and $131.0 million, respectively, compared with $128.8 million and $127.1 million a year ago. Foreign currency translation had the effect of increasing revenue by approximately $8.2 million in the fiscal second quarter versus the prior year comparable period.
The Company's backlog of orders increased $0.7 million during the fiscal second quarter to $32.0 million, which occurred primarily within the Apparel and Flexible Materials segment.
Fiscal second quarter gross margin of 34.4% decreased 1.2 percentage points from the prior year comparable period. Lower business volume, competitive pricing, a sales mix favoring lower margin products, and higher pension expenses were partially offset by cost reductions implemented last fiscal year.
Consolidated S,G,&A spending was lower than the prior year comparable period after adjusting for the effect of foreign currency translation. This was the result of cost reduction initiatives implemented last fiscal year, lower bonus expense, and lower legal and professional expenses. These effects were partially offset by higher pension costs.
Consolidated pension expense was approximately $0.9 million higher in the fiscal second quarter than in the prior year comparable period due primarily to changed assumptions for future pension plan investment performance and discount rates. There have been no subsequent changes to those assumptions.
Consolidated other expense included approximately $1.1 million of foreign currency transaction losses. The Company recognizes foreign currency gains and losses on the payment and translation of accounts payable balances that are reported in one currency and paid in another.
Second quarter restructuring charges of $0.5 million were the result of the transition of the Ophthalmic Lens Processing segment's operations to the Company's shared services platform and the discontinuation of an insignificant product line within the Company's Sign Making and Specialty Graphics segment.
Interest expense increased $1.1 million due to a higher weighted-average interest rate, which was partially offset by lower average debt balances. The Company's weighted average interest rate increased under the terms of the four-year $110.0 million senior credit facility entered into on May 9, 2003.
In the second quarter, the Company recorded a tax benefit of $2.2 million associated with the favorable resolution of a prior year foreign tax issue. Without the tax benefit, the Company's consolidated tax rate from continuing operations would have been 26.4% versus the statutory rate of 35.0%. The difference from the statutory rate was primarily attributable to benefits related to foreign tax planning strategies.
Fiscal Second Quarter Segment Results
Segment profit (defined as earnings before interest and taxes - see attached reconciliation to GAAP measure) for the fiscal second quarter decreased to $9.1 million from $10.8 million in the prior year comparable period.
Sign Making and Specialty Graphics
The Sign Making and Specialty Graphics segment reported revenues of $71.5 million in the fiscal second quarter, an increase of $2.6 million over the prior year comparable period. Foreign currency translation had the effect of increasing revenue by $6.4 million in the second fiscal quarter versus the prior year period. The overall decrease was the result of continued soft economic conditions for this segment's capital equipment products, particularly in Europe. Lower equipment sales in this segment's distribution business was the result of the weaker European economy, competition in inkjet imaging products, and disruption caused by the Company's re-engineering efforts.
Segment profit decreased $0.9 million versus the prior year comparable period. Lower sales volume, competitive price discounting, and higher pension expense ($0.4 million) were partially offset by cost control, lower bonus expense, and contract research and development reimbursements.
Apparel and Flexible Materials
The Apparel and Flexible Materials segment's revenues increased 1.5%, or $0.6 million, to $38.4 million in the second fiscal quarter from the comparable period last year. Foreign currency translation had the effect of increasing revenue by $1.5 million in the fiscal second quarter versus the prior year comparable period.
Segment gross margin of 45.5% decreased 2.3 percentage points from the prior year comparable period due primarily to competitive pricing, but also to the effects of lower sales volume and a sales mix favoring lower margin, multi-ply cutter products versus higher margin, single-ply cutter and software products.
Segment profit increased by $0.5 million over the prior year comparable period despite the lower volume and unfavorable product mix. This resulted from a significant cost reduction associated with the Company's shared services initiative and lower current year bonus expense. Offsetting this, second quarter pension expense was $0.3 million higher than the prior year comparable period.
Segment order entry was $39.0 million, an increase of 5.3% from the prior year and largely the result of favorable foreign currency translation effects. Backlog increased 2.1% from the beginning of the quarter to $28.5 million primarily due to the growth of equipment orders received at the end of the quarter.
Ophthalmic Lens Processing
The Ophthalmic Lens Processing segment reported revenues of $20.4 million, a decrease of $1.7 million from the second quarter of fiscal 2003. The decrease was the result of prior year equipment purchases by large U.S. retail and discount chain customers that did not repeat this year. Higher current year equipment shipments to wholesale optical laboratories were an offset. The effect of foreign currency translation on revenues was not significant.
Segment profit decreased $1.2 million over the prior year comparable period due primarily to the lower sales volume. Also contributing to the decrease were restructuring and other charges associated with the November 1, 2003 transition of segment operations to the Company's shared services and information technology system platforms. Second quarter pension expense was approximately $0.1 million higher than the prior year comparable period in this segment. These unfavorable variances were partially offset by lower bonus expense.
Corporate and Other Expenses
Corporate and other expenses increased to $5.1 million from $4.2 million in the prior year comparable period. Higher pension and insurance costs, as well as foreign currency transaction losses, were partially offset by lower legal and professional expenses and lower bonus expense.
Financial Condition
For the six months ended October 31, 2003, total debt was reduced by $5.2 million, which was the result of operating earnings, reduced cash balances, reduced capital expenditures, and proceeds from the sale of a promissory note in the first quarter.
At October 31, 2003, the Company had $9.7 million in cash and cash equivalents and $80.6 million in total debt. The Company's net debt (defined as total debt less cash and cash equivalents) declined $7.9 million during the second quarter to $71.0 million and the ratio of net debt to capital (defined as the sum of net debt and shareholders' equity) was 40.3%.
The Company was in compliance with all covenants related to its credit facilities as of October 31, 2003. Continued uncertainty in global economic conditions and prolonged weak business environments continue to make estimating demand for the Company's capital equipment products and projecting future results challenging. Although the Company continues to closely monitor compliance with covenants under its credit facilities, failure to be in compliance with any material covenant of the credit facilities could have a material effect on the Company's liquidity, financial position, and results of operations.
Recommendation to Eliminate Classified Board
Upon recommendation of the Nominating and Governance Committee, the Board of Directors unanimously voted to recommend to shareholders for a vote at the Company's 2004 annual meeting charter and bylaw amendments to eliminate the Board's classified structure. If this recommendation should be adopted by at least 80% of the outstanding shares entitled to vote at the Company's 2004 annual meeting, all directors would stand for election or re-election each year beginning at the Company's 2005 annual meeting.
About Gerber Scientific, Inc.
Gerber Scientific, Inc. (http://www.gerberscientific.com) is the world's leading supplier of sophisticated automated manufacturing systems for sign making and specialty graphics, apparel and flexible materials, and ophthalmic lens processing. Headquartered in South Windsor, Connecticut, the Company operates through four businesses: Gerber Scientific Products and Spandex Ltd., Gerber Technology, and Gerber Coburn.
Safe Harbor Statement:
In addition to the historical information contained herein, there are matters discussed that are considered to be "forward-looking statements." The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. These forward-looking statements involve risks and uncertainties, including, but not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, and services, that could significantly affect results in the future. For a discussion of other risk factors relating to the Company's business, see the Company's Quarterly Report on Form 10-Q for the quarter ended July 31, 2003 and its Annual Report on Form 10-K for the year ended April 30, 2003, as filed with the Securities and Exchange Commission. The forward-looking statements contained in this release are made as of the date of this release, and the Company assumes no obligation to update or revise any forward-looking statements contained in this release.
GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
Three Months Ended |
Six Months Ended |
||||
|
In thousands (except per share amounts) |
2003 |
2002 |
2003 |
2002 |
||
|
Revenue: |
||||||
|
Product sales |
$115,747 |
$114,869 |
$230,436 |
$227,096 |
||
|
Service sales |
14,538 |
13,911 |
28,806 |
27,562 |
||
|
130,285 |
128,780 |
259,242 |
254,658 |
|||
|
Costs and Expenses: |
||||||
|
Cost of products sold |
77,701 |
75,799 |
155,336 |
150,613 |
||
|
Cost of services sold |
7,820 |
7,145 |
15,314 |
14,337 |
||
|
Selling, general and administrative |
32,714 |
32,417 |
65,747 |
64,130 |
||
|
Research and development |
6,435 |
6,516 |
12,626 |
12,792 |
||
|
Restructuring charges |
486 |
--- |
486 |
(100) |
||
|
125,156 |
121,877 |
249,509 |
241,772 |
|||
|
Operating income |
5,129 |
6,903 |
9,733 |
12,886 |
||
|
Other income (expense) |
(1,137) |
(340) |
(2,153) |
(1,206) |
||
|
Interest expense |
(3,212) |
(2,146) |
(6,315) |
(4,377) |
||
|
Earnings from continuing operations before |
|
|
|
|
||
|
Provision (benefit) for income taxes |
(1,982) |
1,300 |
(1,860) |
1,964 |
||
|
Earnings from continuing operations |
2,762 |
3,117 |
3,125 |
5,339 |
||
|
Discontinued operations: |
||||||
|
Income from operations of disposed |
|
|
|
|
||
|
Gain on sale of disposed business, net of tax |
--- |
--- |
--- |
1,222 |
||
|
Net earnings |
$ 2,762 |
$ 3,117 |
$ 3,125 |
$ 6,733 |
||
|
======= |
======= |
======= |
======= |
|||
|
Earnings per share of common stock: |
||||||
|
Basic: |
||||||
|
Earnings from continuing operations |
$ .12 |
$ .14 |
$ .14 |
$ .24 |
||
|
Discontinued operations |
--- |
--- |
--- |
.06 |
||
|
Net earnings |
$ .12 |
$ .14 |
$ .14 |
$ .30 |
||
|
======= |
======= |
======= |
======= |
|||
|
Diluted: |
||||||
|
Earnings from continuing operations |
$ .12 |
$ .14 |
$ .14 |
$ .24 |
||
|
Discontinued operations |
--- |
--- |
--- |
.06 |
||
|
Net earnings |
$ .12 |
$ .14 |
$ .14 |
$ .30 |
||
|
======= |
======= |
======= |
======= |
|||
|
Dividends |
$ --- |
$ --- |
$ --- |
$ --- |
||
|
Average shares outstanding: |
||||||
|
Basic |
22,193 |
22,137 |
22,183 |
22,123 |
||
|
Diluted |
22,455 |
22,137 |
22,464 |
22,123 |
||
GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited)
|
|
October 31, 2003 |
April 30, 2003 |
|
|
Assets: |
|||
|
Current Assets: |
|||
|
Cash and cash equivalents |
$ 9,680 |
$ 20,697 |
|
|
Accounts receivable, net of allowance for doubtful |
|
|
|
|
Inventories |
52,736 |
51,982 |
|
|
Deferred income taxes |
3,855 |
5,300 |
|
|
Prepaid expenses and other current assets |
10,330 |
8,327 |
|
|
166,539 |
175,963 |
||
|
Property, Plant and Equipment: |
122,368 |
122,674 |
|
|
Less accumulated depreciation |
77,614 |
75,309 |
|
|
44,754 |
47,365 |
||
|
Intangible Assets: |
|||
|
Goodwill |
50,231 |
48,912 |
|
|
Prepaid pension cost |
8,483 |
8,483 |
|
|
Patents and other intangible assets, net of accumulated amortization |
|
|
|
|
65,432 |
64,172 |
||
|
Deferred Income Taxes |
17,779 |
14,855 |
|
|
Other Assets |
8,913 |
4,336 |
|
|
$303,417 |
$306,691 |
||
|
====== |
====== |
||
|
Liabilities and Shareholders' Equity: |
|||
|
Current Liabilities: |
|||
|
Current maturities of long-term debt |
$ 10,941 |
$ 14,807 |
|
|
Accounts payable |
39,917 |
45,024 |
|
|
Accrued compensation and benefits |
13,766 |
23,167 |
|
|
Other accrued liabilities |
22,646 |
18,202 |
|
|
Deferred revenue |
11,153 |
10,000 |
|
|
Advances on sales contracts |
1,045 |
945 |
|
|
99,468 |
112,145 |
||
|
Noncurrent Liabilities: |
|||
|
Accrued pension benefit liability |
23,549 |
23,549 |
|
|
Other liabilities |
5,517 |
5,534 |
|
|
Long-term debt |
69,704 |
71,000 |
|
|
98,770 |
100,083 |
|
Contingencies and Commitments: |
|||
|
Shareholders' Equity: |
|||
|
Preferred stock, no par value; authorized 10,000,000 shares; no shares issued |
|
|
|
|
Common stock, $1.00 par value; authorized 65,000,000 shares; issued 22,933,421 and 22,908,180 shares |
|
|
|
|
Paid-in capital |
43,624 |
43,703 |
|
|
Retained earnings |
71,037 |
67,912 |
|
|
Treasury stock, at cost (730,635 and 745,184 shares, respectively) |
|
|
|
|
Unamortized value of restricted stock grants |
(151) |
(211) |
|
|
Accumulated other comprehensive loss |
(17,240) |
(24,526) |
|
|
105,179 |
94,463 |
||
|
$303,417 |
$306,691 |
||
|
====== |
====== |
GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
Six Months Ended |
||
|
In thousands |
2003 |
2002 |
|
|
Cash Provided by (Used for): |
|||
|
Operating Activities: |
|||
|
Net earnings |
$ 3,125 |
$ 6,733 |
|
|
Adjustments to reconcile net earnings |
|||
|
Depreciation and amortization |
5,926 |
6,751 |
|
|
Restructuring charges |
486 |
(100) |
|
|
Gain on sale of disposed business, net of taxes |
--- |
(1,222) |
|
|
Deferred income taxes |
(1,855) |
289 |
|
|
Other non-cash items |
1,370 |
550 |
|
|
Changes in operating accounts: |
|||
|
Receivables |
1,101 |
1,360 |
|
|
Inventories |
677 |
(380) |
|
|
Prepaid expenses |
(1,520) |
2,903 |
|
|
Accounts payable and accrued liabilities |
(9,671) |
(4,198) |
|
|
Provided by (Used for) Operating Activities: |
(361) |
12,686 |
|
|
Investing Activities: |
|||
|
Additions to property, plant and equipment |
(1,654) |
(900) |
|
|
Intangible and other assets |
(567) |
(480) |
|
|
Proceeds from sale of assets |
--- |
3,937 |
|
|
Proceeds from sale of disposed business |
--- |
6,595 |
|
|
Proceeds from settlement of promissory note |
994 |
--- |
|
|
Provided by (Used for) Investing Activities: |
(1,227) |
9,152 |
|
|
Financing Activities: |
|||
|
Additions of long-term debt |
170,826 |
3,000 |
|
|
Repayments of long-term debt |
(175,988) |
(16,673) |
|
|
Net short-term financing |
--- |
(205) |
|
|
Debt issue costs |
(5,604) |
(376) |
|
|
Exercise of stock options |
71 |
--- |
|
|
Other common stock activity |
44 |
53 |
|
|
(Used for) Financing Activities: |
(10,651) |
(14,201) |
|
|
Effect of exchange rate changes on cash |
1,222 |
889 |
|
|
Increase (Decrease) in Cash and Cash |
|
|
|
|
Cash and Cash Equivalents, Beginning of Period |
20,697 |
16,220 |
|
|
Cash and Cash Equivalents, End of Period |
$ 9,680 |
$ 24,746 |
|
|
====== |
====== |
||
GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
SEGMENT INFORMATION
|
(Unaudited) |
||||
|
|
Three Months Ended |
Six Months Ended |
||
|
Segment revenue: |
2003 |
2002 |
2003 |
2002 |
|
Sign Making & Specialty Graphics |
$ 71,472 |
$ 68,872 |
$144,313 |
$135,266 |
|
Apparel & Flexible Materials |
38,378 |
37,806 |
75,985 |
76,484 |
|
Ophthalmic Lens Processing |
20,435 |
22,102 |
38,944 |
42,908 |
|
$130,285 |
$128,780 |
$259,242 |
$254,658 |
|
|
======= |
======= |
======= |
======= |
|
|
Segment profit: |
||||
|
Sign Making & Specialty Graphics |
$ 4,509 |
$ 5,431 |
$ 9,578 |
$ 9,920 |
|
Apparel & Flexible Materials |
4,178 |
3,712 |
7,151 |
7,706 |
|
Ophthalmic Lens Processing |
392 |
1,626 |
351 |
2,707 |
|
9,079 |
10,769 |
17,080 |
20,333 |
|
|
Corporate expenses, net of other income |
|
|
|
|
|
Interest expense |
(3,212) |
(2,146) |
(6,315) |
(4,377) |
|
Earnings from continuing |
|
|
|
|
|
======= |
======= |
======= |
======= |
|
Segment profit for the six-month period ended October 31, 2002 included a reversal of previously established restructuring reserves of $100 for the Apparel and Flexible Materials operating segment.
Segment profit for the three and six months ended October 31, 2003 included restructuring charges of $172 for the Sign Making and Specialty Graphics operating segment and $314 for the Ophthalmic Lens Processing operating segment.